Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Spin-Off Company Developing New Antibiotics

MRSA bacteria

A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics

Virtual Reality Therapy Company Gains $5.1M in Early Funds

Scene from VR program

A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round. . . . → Read More: Virtual Reality Therapy Company Gains $5.1M in Early Funds

Univ. Spin-Off Developing A.I.-Boosted Heart Monitor

Heartbeat graphic

A new enterprise in the U.K. is developing a wearable heart monitor that diagnoses irregular heart rhythms with artificial intelligence using cloud-based algorithms. . . . → Read More: Univ. Spin-Off Developing A.I.-Boosted Heart Monitor

Scientists, Investors Form $100M+ Tech Venture Fund

Pen and calculator

A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies. . . . → Read More: Scientists, Investors Form $100M+ Tech Venture Fund

Drug Discovery System Designed to Identify Difficult Targets

Nerve cells in brain

A lab in the U.K. developed a system for discovering new therapies that identify therapy targets linked to enzymes, some found in neurodegenerative diseases, previously considered too difficult to address. . . . → Read More: Drug Discovery System Designed to Identify Difficult Targets

GSK, 23andMe Ink Precision Meds Discovery Deal

Saliva sample kit

Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments. . . . → Read More: GSK, 23andMe Ink Precision Meds Discovery Deal

On Cloud Nine as Remote Computing Transforms Health Care Industry

The health care industry is taking advantage of lower-cost, access-anywhere web-based services and vast amounts of storage for their enormous amounts of patient records and other files. . . . → Read More: On Cloud Nine as Remote Computing Transforms Health Care Industry

More Damage Detected from Crispr-Cas9 Edits

Crispr genome edits illustration

A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood. . . . → Read More: More Damage Detected from Crispr-Cas9 Edits

New $315 Million Life Sciences Venture Fund Unveiled

Investment graphic

A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled

Pet Health Ingredients Shown Effective Against Mosquito-Borne Diseases

Baby with microcephaly

Researchers in the U.S. and the Netherlands found ingredients in over-the-counter products to control fleas and ticks in house pets can also help prevent infectious diseases in humans spread by mosquitoes. . . . → Read More: Pet Health Ingredients Shown Effective Against Mosquito-Borne Diseases